ALCON N | 63.78 / +1.98% |
Date/Time | 03/01 / 17:31 |
Chg. / Chg.(%) | 1.24 / +1.98% |
Bid | 64.70 / 29 |
Ask | - / 66 |
Open | 62.58 |
Previous Close | 62.54 |
High | 64.48 |
Low | 62.58 |
Volume [CHF] | 66,336,419.66 |
Volume [Units] | 1,039,168 |
Price fixings | 6421 |
ISIN | CH0432492467 |
Security | ALC |
Exchange | SIX Swiss Exchange |
Type | Stock |
Bid Size | Bid | Ask | Ask size |
---|---|---|---|
29 | 64.70 | - | 66 |
5 | 63.80 | 63.78 | 14 |
100 | 63.50 | 64.00 | 17 |
500 | 62.56 | 64.70 | 250 |
10 | 62.50 | 64.78 | 500 |
350 | 62.42 | 65.00 | 1,672 |
300 | 62.10 | 65.56 | 350 |
250 | 62.02 | 65.70 | 500 |
530 | 62.00 | 65.90 | 1 |
100 | 61.90 | 65.96 | 1,000 |
News
- Ed TALKS Panel: SolariGate – Avoiding Supply Chain Burns
02/18/2021 / 16:15 - GlobeNewswire - ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome
02/16/2021 / 22:30 - GlobeNewswire - UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor
02/01/2021 / 14:00 - GlobeNewswire - Graybug Vision Appoints Bettina Maunz as Chief People Officer, Expanding the Company’s Executive Team
02/01/2021 / 13:30 - GlobeNewswire - ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
12/22/2020 / 13:00 - GlobeNewswire